New England Capital Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $287K | Buy |
6,200
+13
| +0.2% | +$602 | 0.13% | 47 |
|
|
2025
Q1 | $377K | Sell |
6,187
-189
| -3% | -$11.5K | 0.19% | 39 |
|
|
2024
Q4 | $361K | Buy |
6,376
+11
| +0.2% | +$622 | 0.18% | 39 |
|
|
2024
Q3 | $329K | Buy |
6,365
+13
| +0.2% | +$673 | 0.17% | 40 |
|
|
2024
Q2 | $264K | Buy |
6,352
+14
| +0.2% | +$581 | 0.15% | 45 |
|
|
2024
Q1 | $344K | Buy |
6,338
+12
| +0.2% | +$651 | 0.19% | 36 |
|
|
2023
Q4 | $325K | Buy |
6,326
+11
| +0.2% | +$564 | 0.2% | 37 |
|
|
2023
Q3 | $367K | Buy |
6,315
+9
| +0.1% | +$522 | 0.25% | 32 |
|
|
2023
Q2 | $403K | Buy |
6,306
+8
| +0.1% | +$512 | 0.27% | 31 |
|
|
2023
Q1 | $437K | Buy |
6,298
+7
| +0.1% | +$485 | 0.31% | 28 |
|
|
2022
Q4 | $466K | Buy |
+6,291
| New | +$466K | 0.33% | 26 |
|